Edgardo Chapman
Bogota, DC, Colombia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Prevalence of adverse reactions and food allergies in Colombia: Cross-sectional national study.
Journal: The journal of allergy and clinical immunology. Global
Published: August 26, 2025
Selection of allergen extract for immunotherapy in polysensitized allergic rhinitis patients.
Journal: Immunotherapy
Published: July 25, 2024
Consensus for the treatment of atopic dermatitis in primary care: resolving myths and legends based on evidence
Journal: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
Published: June 25, 2024
Case report: desensitization of hypersensitivity against the antisense oligonucleotide volanesorsen.
Case report: desensitization of hypersensitivity against the antisense oligonucleotide volanesorsen.
Journal: Frontiers in allergy
Published: April 07, 2023
Effectiveness and safety of dupilumab in adults with moderate and severe atopic dermatitis in Colombia: Real-life experience.
Journal: The World Allergy Organization journal
Published: October 05, 2022
Control of allergic rhinitis in four latin american countries: Rinola study.
Journal: Frontiers in allergy
Published: June 28, 2022
Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms.
Journal: The Journal of allergy and clinical immunology
Published: April 29, 2022
Frequency of self-reported allergies at a high-complexity referral hospital in Colombia, a tropical Latin American country.
Journal: Allergologia et immunopathologia
Published: May 19, 2021
Effect of the COVID-19 pandemic on the mental health, daily and occupational activities of otolaryngologists and allergists in Colombia: a national study.
Journal: International forum of allergy & rhinology
Published: January 20, 2021
Effectiveness and adverse events of topical and allergen immunotherapy for atopic dermatitis: a systematic review and network meta-analysis protocol.
Journal: Systematic reviews
Published: March 10, 2020
Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A serie of cases.
Journal: Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
Published: October 14, 2019
Last Updated: 09/26/2026